Sebastian Kull

Sebastian Kull is a Consultant at Dolon Ltd, specializing in strategic pricing and market access consulting, particularly in the area of rare diseases. He has a robust educational background, holding a Master's degree from the Karolinska Institute in Stockholm, Sweden, and a Bachelor's degree from Heidelberg University in Germany, where he focused on biotechnology.

Kull has built his expertise through various roles, including Market Access Analyst and Associate Consultant at Synergus AB, where he gained significant experience in pharmaceuticals and medical technology. His professional journey also includes positions as a research assistant and intern at organizations such as Industrifonden and aquila biolabs. Kull is noted for his strong analytical skills and a deep interest in healthcare innovation and research.1